A perspective on complementary/alternative medicine use among survivors of hematopoietic stem cell transplant: Benefits and uncertainties
Rajshekhar Chakraborty(Columbia University Irving Medical Center), Shahrukh K. Hashmi(Sheikh Shakhbout Medical City), Mohamad Mohty(Inserm), Bipin N. Savani(Vanderbilt University Medical Center), Mark R. Litzow(Toyota Motor Corporation (Switzerland))
Cited by 24
Related Papers
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease
|New England Journal of Medicine|2020|859
Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results
|Nature Medicine|2023|534
Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research
|Biology of Blood and Marrow Transplantation|2014|435
One million haemopoietic stem-cell transplants: a retrospective observational study
|The Lancet Haematology|2015|434